Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Cancers|November 19, 2020
Ex Vivo Expansion and Drug Sensitivity Profiling of Circulating Tumor Cells from Patients with Small Cell Lung CancerHsin-Lun Lee, Jeng-Fong Chiou, Peng-Yuan Wang, et al.
Molecular Nutrition & Food Research|March 19, 2013
Pterostilbene, a bioactive component of blueberries, suppresses the generation of breast cancer stem cells within tumor microenvironment and metastasis via modulating NF-κB/microRNA 448 circuitKa-Kit Mak, Alexander T H Wu, Wei-Hwa Lee, et al.
Experimental Cell Research|August 7, 2010
Increased cellular apoptosis susceptibility (CSE1L/CAS) protein expression promotes protrusion extension and enhances migration of MCF-7 breast cancer cellsCheng-Jeng Tai, Shing-Chuan Shen, Woan-Ruoh Lee, et al.
Cancers|July 9, 2022
Skin Surface Dose for Whole Breast Radiotherapy Using Personalized Breast Holder: Comparison with Various Radiotherapy Techniques and Clinical ExperiencesChiu-Ping Chen, Chi-Yeh Lin, Chia-Chun Kuo, et al.
International Journal of Radiation Oncology, Biology, Physics|September 8, 2020
Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival and Liver Toxicity in Patients With Hepatocellular Carcinoma Treated With Stereotactic Ablative Radiation TherapyCheng-Hsiang Lo, Hsin-Lun Lee, Chih-Weim Hsiang, et al.
Cancers|December 10, 2021
Ex Vivo Expanded Circulating Tumor Cells for Clinical Anti-Cancer Drug Prediction in Patients with Head and Neck CancerKuan-Chou Lin, Lai-Lei Ting, Chia-Lun Chang, et al.
The International Journal of Biological Markers|June 2, 2012
Presence of CSE1L protein in urine of patients with urinary bladder urothelial carcinomasCheng-Jeng Tai, Ching-Fong Liao, Tzu-Cheng Su, et al.
Molecular Medicine (Cambridge, Mass.)|September 7, 2012
CSE1L, a novel microvesicle membrane protein, mediates Ras-triggered microvesicle generation and metastasis of tumor cellsChing-Fong Liao, Shu-Hui Lin, Hung-Chang Chen, et al.
Diagnostics (Basel, Switzerland)|May 13, 2023
Effectiveness of Stereotactic Ablative Radiotherapy for Systemic Therapy Respondents with Inoperable Pulmonary Oligometastases and OligoprogressionChin-Beng Ho, Jo-Ting Tsai, Chun-You Chen, et al.
Therapeutic Advances in Medical Oncology|December 17, 2019
Effectiveness of stereotactic ablative radiotherapy in patients with advanced hepatocellular carcinoma unsuitable for transarterial chemoembolizationHsin-Lun Lee, Jo-Ting Tsai, Chun-You Chen, et al.
Pageof 11